- IMPROVE IT: The use of ezetimibe and simvastatin (Vytorin®) vs. simvastatin (Zocor®) in acute coronary syndrome patients that have undergone percutaneous coronary intervention. Principal Investigator: Luis Gruberg, MD
- M&M - Dal OUTCOMES: The use of a new drug that increases HDL cholesterol (dalcetrapib), in acute coronary syndrome patients who underwent coronary intervention. Principal Investigator: Luis Gruberg, MD
- ZESCA: The use of bupropion (Zyban®) in acute coronary syndrome patients that smoke and want to quit smoking. Principal Investigator: Luis Gruberg, MD
